Opinion|Videos|July 1, 2024
RSV: Risk Factors and How It’s Spread
A panel of experts outline who’s at risk for RSV and how it’s spread, highlighting how transmission can be minimized.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- Who is at risk for respiratory syncytial virus (RSV) and how prevalent is RSV among older adults?
- What is the mortality rate associated with RSV infections?
- How is RSV spread and what are the typical symptoms for RSV?
- How can infected people minimize the spread of RSV?
- How can infected people minimize the spread of RSV?
Advertisement
Related to this article
FDA granted accelerated approval to dostarlimab-gxly for dMMR or MSI-H locally advanced rectal cancer based on interim phase 2 AZUR-1 results.
Phentolamine 0.75% (Ryzumvi) won FDA approval for presbyopia based on the phase 3 VEGA-2 and VEGA-3 trials.
Nearly 3 in 4 bariatric surgery candidates had clinical obesity, a phenotype that BMI alone did not distinguish from preclinical obesity.
Satralizumab, a first-in-class IL-6 receptor inhibitor, was approved for adults with thyroid eye disease based on the phase 3 SatraGO program.
A review of 47 endometriosis guidelines found most came from high-income settings and diverged on biomarkers, repeat surgery, and fertility referral.
The meeting covered several topics in eye care, including how artificial intelligence (AI) can play a part in eye care.
A meta-analysis of 27 trials found a 15% cardiovascular risk reduction per 10-mm Hg lower systolic BP, with no added risk of kidney failure.
In a Japanese registry of 1235 patients with AMI treated with PCI, Lp(a) of 24 mg/dL or higher independently predicted MACE and HF hospitalization.
Advertisement
Advertisement
Trending on AJMC
1
Pathological Response Does Not Reliably Predict Survival in Sarcoma
2
New CHEST Guidelines Offer a Road Map for Bronchiectasis
3
CHEST Investigations Explore COPD Guideline Adherence, Adding Ensifentrine, and Use of AI in Education
4
CHEST Highlights Practice-Changing COPD Therapy and Strategies
5